Riskpilot← Back to searchSign inGet full accessOtimator AB
ABActiveOrg 5569499238Lerbrännargatan 3 AMedical specialists activities · NACE 8622Est. 20131 employees
Revenue 2025
SEK 1,4M
-46% vs 2024
EBITDA margin
-5.0%
+80% vs 2024
Equity ratio
-251.5%
Financial strength
Net profit 2025
SEK -109K
+71% vs 2024
| Revenue | SEK 1,4M | -46% |
| EBITDA | SEK -72K | +80% |
| Net profit | SEK -109K | +71% |
| Total assets | SEK 134K | -36% |
| Equity | SEK -337K | -16% |
| Employees | 1 | — |
Legal name
Otimator AB
Org number
5569499238
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 november 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall vara verksamt inom följande områden: 1) Egen läkarverksamhet 2) Uthyrning av läkare och sjuksköterskor 3) Import av viner 4) Export av öl och matvaror 5) Export av diverse hushållsutrustning
Address
Lerbrännargatan 3 A
Phone
+46736515235
Email
bengt@otimator.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 214 | 6 122 | 5 106 | 2 686 | 1 442 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 54 | 382 | 560 | −367 | −72 |
| Depreciation & amort. | −28 | −28 | −7 | −0 | −0 |
| EBIT | 26 | 354 | 553 | −367 | −72 |
| Net financials | −2 | −4 | −8 | −10 | −38 |
| Profit before tax | 224 | 344 | 552 | −377 | −109 |
| Tax | −52 | −72 | −116 | −0 | −0 |
| Net profit | 172 | 272 | 436 | −377 | −109 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 913 | 744 | 798 | 210 | 134 |
| Equity | 464 | 336 | 487 | −290 | −337 |
| Long-term debt | 0 | 0 | 0 | 409 | 412 |
| Short-term debt | 1 449 | 401 | 311 | 91 | 58 |
| Total debt | 1 449 | 401 | 311 | 500 | 470 |
EBITDA margin
-5.0%
This company
15.8%
Market median
-132% vs market
20212025
Equity ratio
-251.5%
This company
38.2%
Market median
-758% vs market
20212025
Return on equity
-10900000.0%
This company
18.4%
Market median
-59239230% vs market
20212025
Net profit margin
-7.6%
This company
8.1%
Market median
-194% vs market
20212025
Asset turnover
10.76×
This company
1.12×
Market median
+861% vs market
20212025
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BO Chief Executive Officer | Chief Executive Officer | 2020 |
CO | Audit | 2022 |
| Former (2) | ||
| Audit | 2020 – 2022 | |
MM | Audit | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Otimator AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Louise Rebecka Thérese Jonasson | Audit | 0 companies |
| Bengt Olof Sunnerstam | Chief Executive Officer | 0 companies |
| Carl Oscar Nils Bengtsson | Audit | 0 companies |
| Maggie Margaretha Fagergren | Audit | 0 companies |
| Britt Margaretha Gradin | Deputy Board Member | 0 companies |